Table 4.
HL-COVID levels of thematic subdimensions by participant characteristics.
| Study Population | Protect | Prevent | Recognize | Deal | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Excellent | Sufficient | Limited | Excellent | Sufficient | Limited | Excellent | Sufficient | Limited | Excellent | Sufficient | Limited | |
| Total (n = 3500) | ||||||||||||
| Sex | ||||||||||||
| Male | 49.5 | 18.1 | 32.4 | 53.1 | 15.4 | 31.5 | 35.1 | 15.4 | 45.4 | 47.1 | 15.6 | 37.3 |
| Female | 48.1 | 19.8 | 32.1 | 54.6 | 13.7 | 31.6 | 36.6 | 13.7 | 44.4 | 46.6 | 15.5 | 38.0 |
| Age class | ||||||||||||
| 18–29 | 52.2 | 21.8 | 26.0 | 63.2 | 13.4 | 23.4 | 39.7 | 20.1 | 40.2 | 56.6 | 15.2 | 28.2 |
| 30–44 | 46.6 | 17.6 | 35.9 | 55.4 | 14.0 | 30.6 | 33.2 | 21.4 | 45.4 | 48.5 | 16.8 | 34.7 |
| 45–64 | 50.5 | 17.6 | 32.0 | 53.2 | 13.7 | 33.1 | 38.0 | 18.4 | 43.7 | 46.2 | 14.1 | 39.7 |
| 65+ | 46.8 | 20.7 | 32.5 | 48.9 | 16.6 | 34.5 | 33.7 | 18.0 | 48.4 | 41.4 | 16.5 | 42.1 |
| Education | ||||||||||||
| Low | 45.9 | 19.2 | 34.9 | 50.7 | 15.0 | 34.3 | 33.8 | 19.7 | 46.5 | 44.3 | 16.6 | 39.1 |
| Medium | 50.4 | 18.5 | 31.1 | 55.2 | 14.3 | 30.5 | 38.1 | 18.2 | 43.7 | 47.0 | 14.7 | 38.2 |
| High | 51.7 | 19.4 | 28.9 | 58.0 | 14.0 | 28.0 | 36.2 | 20.0 | 43.8 | 51.4 | 14.9 | 33.7 |
| Geographic area | ||||||||||||
| Northwest | 49.0 | 18.1 | 32.9 | 54.6 | 13.1 | 32.3 | 36.4 | 19.0 | 44.5 | 48.4 | 13.8 | 37.8 |
| Northeast | 45.0 | 23.1 | 31.9 | 48.8 | 18.5 | 32.7 | 32.8 | 20.3 | 46.9 | 43.3 | 19.4 | 37.3 |
| Center | 51.0 | 20.8 | 28.1 | 58.0 | 15.4 | 26.6 | 39.2 | 21.2 | 39.6 | 49.6 | 17.2 | 33.2 |
| South and islands | 49.6 | 16.0 | 34.3 | 54.0 | 12.7 | 33.3 | 35.5 | 17.5 | 47.0 | 46.1 | 13.5 | 40.4 |
| Deprivation | ||||||||||||
| No | 56.0 | 20.6 | 23.4 | 61.4 | 15.1 | 23.5 | 40.5 | 22.3 | 37.2 | 54.4 | 16.0 | 29.7 |
| Some | 47.8 | 17.5 | 34.7 | 53.2 | 13.7 | 33.1 | 35.6 | 18.9 | 45.5 | 47.6 | 15.2 | 37.1 |
| Considerable | 43.8 | 18.7 | 37.5 | 49.8 | 14.9 | 35.3 | 32.6 | 17.7 | 49.8 | 40.9 | 15.8 | 43.3 |
| Severe | 37.2 | 16.5 | 46.4 | 40.5 | 14.2 | 45.3 | 27.3 | 15.2 | 57.5 | 32.8 | 15.9 | 51.3 |
| GEN-HL quartile | ||||||||||||
| First | 16.9 | 19.2 | 63.9 | 18.6 | 14.1 | 67.3 | 10.1 | 11.7 | 78.2 | 13.3 | 11.3 | 75.4 |
| Second | 39.1 | 26.1 | 34.8 | 44.8 | 20.2 | 35.0 | 25.6 | 20.8 | 53.7 | 33.9 | 22.8 | 43.3 |
| Third | 55.3 | 23.4 | 21.3 | 64.3 | 18.3 | 17.4 | 39.1 | 27.5 | 33.4 | 54.9 | 20.8 | 24.3 |
| Fourth | 84.4 | 7.5 | 8.2 | 88.3 | 5.8 | 5.9 | 69.4 | 17.1 | 13.5 | 85.5 | 7.7 | 6.8 |
| HL Vaccination | ||||||||||||
| Excellent | 70.7 | 13.9 | 15.4 | 75.5 | 11.0 | 13.5 | 56.0 | 18.6 | 25.4 | 69.3 | 12.6 | 18.1 |
| Sufficient | 39.5 | 27.4 | 33.1 | 47.9 | 21.1 | 31.1 | 25.7 | 25.4 | 48.9 | 38.8 | 20.4 | 40.8 |
| Limited | 23.2 | 21.0 | 55.8 | 26.0 | 15.5 | 58.5 | 14.1 | 16.1 | 69.8 | 18.4 | 16.7 | 64.9 |